Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

DRUG(2)

BIOLOGICAL(2)

BEHAVIORAL(1)

Convalescent Plasma (anti-SARS-CoV-2 plasma)

1 trial

phase_2

andrew-eisenberger

Once Daily Application of TFV RG 1% Gel - Vaginal

Once Daily Application of TFV RG 1% gel - Rectal

1 trial

phase_1

conrad

5 unique interventions3 categories

Analytics

Trial Phases

Phase 11

Phase 21

Trial Status

Completed3

Terminated1

Role Distribution

Principal Investigator3

Other Roles1

PI Rate75%

Activity Timeline

Clinical Trials (4)

NCT05111119Not ApplicableCompleted

Making PrEP Smart: An HIV Testing and PrEP Electronic Support Tool ("SmartPrEP" App) for Women on PrEP

HIV/AIDS

PrincipalinvestigatorStart date: 2022-02-03

NCT04390503Phase 2Terminated

Convalescent Plasma for Early Treatment of COVID-19

COVID-19SARS-CoV 2

PrincipalinvestigatorStart date: 2021-03-12

NCT04117984Completed

Swaziland HIV Incidence Measurement Survey 2

HIV/AIDS

StudydirectorStart date: 2016-08-30

NCT01768962Phase 1Completed

Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel

HIV Prevention

Principalinvestigator

Research Network

Collaboration Network

4 collaborators·4 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

HIV/AIDS2 COVID-191 HIV Prevention1 SARS-CoV 21

Affiliations

Columbia University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sabine Hazan, MD

ProgenaBiome

41 trials

Shared therapeutic areas:

COVID-19SARS-CoV 2

Similarity Score15%

Gonasagrie Nair, MBChB

Centre for the AIDS Programme of Research in South Africa (CAPRISA) - eThekwini CRS

1 trials

Shared therapeutic areas:

HIV Prevention

Worked with same sponsors:

CONRADEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)+2 more

Collaborated on 1 trial

Similarity Score14%

David Hoos, MD

Columbia University

1 trials

Shared therapeutic areas:

HIV/AIDS

Worked with same sponsors:

Centers for Disease Control and PreventionColumbia University+1 more

Collaborated on 1 trial

Similarity Score14%

Harriet Nuwagaba-Biribonwoha, MD

Columbia University

1 trials

Shared therapeutic areas:

HIV/AIDS

Worked with same sponsors:

Centers for Disease Control and PreventionColumbia University+1 more

Collaborated on 1 trial

Similarity Score14%

Xiaolong Qi, MD

LanZhou University

8 trials

Shared therapeutic areas:

COVID-19

Similarity Score8%

Toshimitsu Tokimoto

Astrazeneca KK

16 trials

Shared therapeutic areas:

COVID-19

Similarity Score8%

Wenhong Zhang, MD

Huashan Hospital

4 trials

Shared therapeutic areas:

COVID-19

Similarity Score8%

Mitchell S Cairo, MD

New York Medical College

13 trials

Shared therapeutic areas:

COVID-19

Similarity Score8%

Shai a Efrati, MD

Asaf-Harofhe MC

13 trials

Shared therapeutic areas:

COVID-19

Similarity Score8%

Mohamed mamdouh Elsayed, MD

Lecturer

11 trials

Shared therapeutic areas:

COVID-19

Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT05111119Not ApplicablePrincipalInvestigator

Making PrEP Smart: An HIV Testing and PrEP Electronic Support Tool ("SmartPrEP" App) for Women on PrEP

HIV/AIDS

Completed

NCT04390503Phase 2PrincipalInvestigator

Convalescent Plasma for Early Treatment of COVID-19

COVID-19SARS-CoV 2

Terminated

NCT04117984StudyDirector

Swaziland HIV Incidence Measurement Survey 2

HIV/AIDS

Completed

NCT01768962Phase 1PrincipalInvestigator

Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel

HIV Prevention

Completed

All 4 trials loaded